Insulin-like growth factor binding proteins 3 and 5 are overexpressed in idiopathic pulmonary fibrosis and contribute to extracellular matrix deposition
about
WNT5A is a regulator of fibroblast proliferation and resistance to apoptosisEpithelial neoplasia coincides with exacerbated injury and fibrotic response in the lungs of Gprc5a-knockout mice following silica exposureMatrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosisGene expression profiling of pulmonary fibrosis identifies Twist1 as an antiapoptotic molecular "rectifier" of growth factor signalingFibrocyte CXCR4 regulation as a therapeutic target in pulmonary fibrosisMining the acute respiratory distress syndrome proteome: identification of the insulin-like growth factor (IGF)/IGF-binding protein-3 pathway in acute lung injuryMatrix metalloproteinase-19 is a key regulator of lung fibrosis in mice and humansTargeting insulin-like growth factor-I and insulin-like growth factor-binding protein-3 signaling pathways. A novel therapeutic approach for asthmaThe role of microRNA-155/liver X receptor pathway in experimental and idiopathic pulmonary fibrosisRole of IGF-I, IGF-II and IGFBP-3 in lung function of males: the Caerphilly Prospective StudyGene profiling of keloid fibroblasts shows altered expression in multiple fibrosis-associated pathways.Decreased caveolin-1 levels contribute to fibrosis and deposition of extracellular IGFBP-5.Syndecan-2 is a novel target of insulin-like growth factor binding protein-3 and is over-expressed in fibrosis.Antifibrotic effects of roscovitine in normal and scleroderma fibroblasts.Lung fibroblasts from patients with emphysema show markers of senescence in vitro.Increased constitutive αSMA and Smad2/3 expression in idiopathic pulmonary fibrosis myofibroblasts is KCa3.1-dependent.Upregulation of activin-B and follistatin in pulmonary fibrosis - a translational study using human biopsies and a specific inhibitor in mouse fibrosis models.The K+ channel KCa3.1 as a novel target for idiopathic pulmonary fibrosisMechanosignaling through YAP and TAZ drives fibroblast activation and fibrosisThe membrane-associated adaptor protein DOK5 is upregulated in systemic sclerosis and associated with IGFBP-5-induced fibrosis.Lung tissues in patients with systemic sclerosis have gene expression patterns unique to pulmonary fibrosis and pulmonary hypertension.IGFBP7, a novel tumor stroma marker, with growth-promoting effects in colon cancer through a paracrine tumor-stroma interaction.Fibrotic response in fibroblasts from congenital disorders of glycosylation.Human lung myofibroblast TGFβ1-dependent Smad2/3 signalling is Ca(2+)-dependent and regulated by KCa3.1 K(+) channelsInsulin-like growth factor-binding protein-5 induces pulmonary fibrosis and triggers mononuclear cellular infiltrationIGFBP-5 Promotes Fibrosis Independently of Its Translocation to the Nucleus and Its Interaction with Nucleolin and IGF.Inhibition of focal adhesion kinase prevents experimental lung fibrosis and myofibroblast formation.Autophagy releases lipid that promotes fibrogenesis by activated hepatic stellate cells in mice and in human tissues.Profibrotic role of miR-154 in pulmonary fibrosis.Insulin-like growth factor-II is increased in systemic sclerosis-associated pulmonary fibrosis and contributes to the fibrotic process via Jun N-terminal kinase- and phosphatidylinositol-3 kinase-dependent pathwaysTruncated Plasminogen Activator Inhibitor-1 Protein Protects From Pulmonary Fibrosis Mediated by Irradiation in a Murine Model.Matrices of physiologic stiffness potently inactivate idiopathic pulmonary fibrosis fibroblasts.Estradiol promotes the development of a fibrotic phenotype and is increased in the serum of patients with systemic sclerosisAdenoviral overexpression and small interfering RNA suppression demonstrate that plasminogen activator inhibitor-1 produces elevated collagen accumulation in normal and keloid fibroblastsHuman skin culture as an ex vivo model for assessing the fibrotic effects of insulin-like growth factor binding proteinsComplement C5 regulates the expression of insulin-like growth factor binding proteins in chronic experimental allergic encephalomyelitis.IGF1 and IGFBP3 in acute respiratory distress syndromeNOX4 mediates hypoxia-induced proliferation of human pulmonary artery smooth muscle cells: the role of autocrine production of transforming growth factor-{beta}1 and insulin-like growth factor binding protein-3.Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitisUpregulation of RGS2: a new mechanism for pirfenidone amelioration of pulmonary fibrosis
P2860
Q24316338-AAB34114-31CE-4492-A076-3AC4C21B4D86Q28385959-BE14C7F6-8AA4-448A-A1E6-E5B651707C64Q28386047-026009C0-9296-4876-9A9F-862788458C27Q28571857-72B23574-8212-4640-B374-2E73A3E3F412Q30435304-8BA90516-40BD-4013-B858-712A1672D8A9Q30478475-F67BD14F-41A3-4BDA-BD10-9C4760C186C8Q33745690-BF61B9F8-A8D8-4289-B9A8-82A4F288895FQ33756365-5A5B3410-CA7A-4962-A46C-C0503586ABBCQ33758285-1D6E496F-0D1B-4533-9F83-7A1EF32C4DBFQ33785570-D534C170-5CD2-46E5-83A3-3564E822ED9FQ34102567-1FCD26F7-58F6-41B5-AF06-4BAD6F200415Q34367785-92F0A9B6-D6AD-4273-84E1-1BC455E002FBQ34382756-B220D9CE-B812-4812-A3ED-D16378D5A910Q34489708-12140D6E-F319-43EF-A6AE-05C4A6F96356Q34537637-BD711352-AE42-42E1-851F-CCD6EEBAF61CQ34677065-2DB1FCC6-F3E7-4547-AECC-D3924DBF32D2Q34738988-EECF5F74-367C-4340-AB13-1541CE6285B6Q35083097-76E8C3BE-03A1-4214-B2EA-9E56C1B98FA8Q35086389-2842A680-EB8C-42DF-9CE5-04DBBDB07C3FQ35097280-6640639A-84A5-4C1B-9D9B-40481959504AQ35116144-F26A460F-F3B2-4038-B1F1-B9AB4619EC92Q35121572-E3686A8A-088B-41C5-8F92-232FF14EE2ECQ35216162-DAE90F60-7743-405F-ADB1-47612F0EFE67Q35232951-71500E32-6E08-457E-8EFC-B7A6523DD332Q35607286-6856664B-4C3E-44EB-A616-878B339A7E29Q35672107-F4AEBC89-D7B5-466C-927F-3D5DE95B6401Q35918710-A32A2738-2CE0-4BBC-A1E1-10E13B81B1B9Q36227227-61DF42AB-F625-4FAC-B96E-1827291AB058Q36539603-B5CAED59-E022-49CE-9C52-D3DEA0FDEA9BQ36691084-5FCCE086-F5AF-4CD7-9780-B763635A2272Q36819764-C4AE26BB-E6B4-45C9-8C3C-8B5300A4312CQ36842944-C795B2F7-803E-408E-955A-813C3383CE1AQ36903132-C1A9AE68-416B-4439-9998-090314EBCE74Q36943056-60C1F337-EC2C-426F-925D-25DD7842D698Q36961582-5AB263FA-AA52-4202-9CC0-54574AC87063Q37034172-0BB3C361-D939-4EAE-849B-63BA0441B008Q37133007-0DA89B9B-15A3-4C12-BD1D-797EBB7653E5Q37138896-025C5C89-C75D-41A8-B383-AC1E4BCE4D1CQ37144567-52E9181D-3BD9-4986-AFB1-E1E47C103CE0Q37196021-1DEB98D3-0402-4108-BD38-8829B07E6C51
P2860
Insulin-like growth factor binding proteins 3 and 5 are overexpressed in idiopathic pulmonary fibrosis and contribute to extracellular matrix deposition
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Insulin-like growth factor bin ...... xtracellular matrix deposition
@ast
Insulin-like growth factor bin ...... xtracellular matrix deposition
@en
type
label
Insulin-like growth factor bin ...... xtracellular matrix deposition
@ast
Insulin-like growth factor bin ...... xtracellular matrix deposition
@en
prefLabel
Insulin-like growth factor bin ...... xtracellular matrix deposition
@ast
Insulin-like growth factor bin ...... xtracellular matrix deposition
@en
P2093
P2860
P921
P1476
Insulin-like growth factor bin ...... xtracellular matrix deposition
@en
P2093
Adam C Henry
Alycia V Knauer
Carol A Feghali-Bostwick
Joseph M Pilewski
P2860
P304
P356
10.1016/S0002-9440(10)62263-8
P407
P577
2005-02-01T00:00:00Z